Literature DB >> 28593841

Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?

Winette T A van der Graaf1, Robin L Jones2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28593841     DOI： 10.1016/S1470-2045(17)30330-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety.

Authors:  Jia-Yan Ni; Hong-Liang Sun; Yao-Ting Chen; Jiang-Hong Luo; Wei-Dong Wang; Xiong-Ying Jiang; Dong Chen; Lin-Feng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-09       Impact factor: 4.553

2.  Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study.

Authors:  Zhiyong Liu; Cuiping Liu; Weitao Yao; Songtao Gao; Jiaqiang Wang; Peng Zhang; Hong Ge
Journal:  Anticancer Drugs       Date:  2021-10-01       Impact factor: 2.248
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.